<- Go Home
Zentek Ltd.
Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis. In addition, the company owns 100% interest in the Albany graphite project located in Northern Ontario, Canada. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Guelph, Canada.
Market Cap
CAD 171.7M
Volume
50.6K
Cash and Equivalents
CAD 2.9M
EBITDA
-CAD 9.7M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
-CAD 440.1K
Profit Margin
1118.24%
52 Week High
CAD 2.12
52 Week Low
CAD 0.75
Dividend
N/A
Price / Book Value
9.25
Price / Earnings
-15.07
Price / Tangible Book Value
9.25
Enterprise Value
CAD 169.7M
Enterprise Value / EBITDA
-17.83
Operating Income
-CAD 10.1M
Return on Equity
49.39%
Return on Assets
-25.81
Cash and Short Term Investments
CAD 2.9M
Debt
CAD 923.5K
Equity
CAD 18.6M
Revenue
CAD 39.4K
Unlevered FCF
-CAD 1.1M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium